The Team That Makes The Difference

The Excelerate Health Team is built around core skill sets of investment experience, deep healthcare sector expertise, and company growth management. Our operational team is supported by a recognized, actively engaged, and committed advisory board. We are members of the healthcare community. We have the unique ability to identify deeply unresolved needs and have insight into innovative solutions. Our understanding of healthcare positions us at the center of innovative discoveries. Our investments often leverage the interdisciplinary nature and backgrounds of our team. We know firsthand what it takes to build a successful company – from inception through the sale. We are entrepreneurs ourselves; we have launched and financed companies, managed growth, and negotiated acquisitions.

Partners

Bobby Bahram Biography

Managing Partner

Bobby Bahram Biography

Bobby Bahram is a seasoned executive with 25 years of experience in building and scaling start-up companies, with a particular focus on the healthcare sector. As a co-founder of Excelerate Health Ventures, a leading venture capital fund, Mr. Bahram has been instrumental in sourcing, conducting due diligence, structuring, and leading investment rounds in healthcare software and tech-enabled healthcare services sectors. Throughout his career, Mr. Bahram has served as a director for multiple healthcare companies, where he has significantly contributed to successful spin-offs, mergers, and acquisitions. His expertise lies in developing and executing strategies for sustainable growth across software, hardware, and services sectors, while adeptly navigating complex financial, organizational, and legal challenges. Mr. Bahram has held several executive roles in technology-driven start-ups, including serving as various companies’ founding CEO and CFO/COO. In addition to his executive leadership, he is a frequent speaker on entrepreneurial topics. Mr. Bahram earned an M.B.A. with concentrations in Technology Commercialization and Finance from North Carolina State University, and a B.S., with high honors, in Electrical Engineering from Clemson University.

Maulik Mehta Biography

Managing Partner

Maulik Mehta Biography

Maulik Mehta is a seasoned executive with a more than 25 years of experience in life sciences, healthcare technologies, and chemical industries. Mr. Mehta has extensive experience in global business development, corporate strategy, and mergers and acquisitions. Mr. Mehta has consistently driven growth and innovation in healthcare and pharmaceutical services through data analytics and technology. Mr. Mehta’s leadership roles have spanned various capacities, including most recently as President and Chief Business Officer at TriNetX, VP of Corporate Development at Quintiles, and Director of Investment Analytics at NovaQuest Capital. Mr. Mehta is passionate about leveraging technology to improve healthcare outcomes and is actively involved in strategic partnerships that enhance organizational capabilities. Mr. Mehta currently holds several board and advisory positions. Mr. Mehta holds an M.B.A. in Finance and General Management from Wake Forest University and a B.S. degree with honors in Chemistry from North Carolina State University.

Andrew Schwab Biography

Managing Partner

Andrew Schwab Biography

Andrew Schwab is a successful entrepreneur and investor with over 25 years experience building and growing technology-focused startup companies. He was a special limited partner for Excelerate Health Ventures’ Fund I. He has held C-level executive roles in four startup technology companies spanning internet software development through personalized medicine and has negotiated two successful exits. As a seasoned executive with proven management and startup skills, he has led two companies featured in the Triangle Fast 50 for their outstanding revenue growth. Most recently, he has led the resurgence of the First Flight Venture Center mentoring 30 healthcare technology companies at a time in a wide range of complex business issues including financing, operational challenges, and strategic mergers and acquisitions. An active investor for over twenty years and a founder of RTP Capital, recently recognized by the Angel Capital Association as one of the region’s most active investor networks. Dr. Schwab was the recipient of the individual Lifetime Achievement Award in Life Sciences. He earned an M.S. and PhD. in Electrical Engineering from the University of Virginia, and he holds a B.S. in Electrical Engineering from Duke University.

Venture Partners

Gary Abrahams Biography

Venture Partner

Gary Abrahams Biography

Gary Abrahams has 30 years of sales, marketing, product management, business and market development experience in the healthcare industry for both startups and large corporations. He has been an active investor since 2013, including a managing partner with EHV Fund I. Mr. Abrahams has deep expertise in the healthcare enterprise, mobile, clinical, business and imaging software, services, and medical devices. He was the Global Director of a $400M market-leading business for HP Medical; Senior Director of Marketing and Sales for DuPont Pharmaceuticals; VP of Marketing and International Sales for Volumetrics Medical Imaging; VP of Marketing and Business Development for HealthGate Data Corp; GM for t+Medical; and in less than 5 years he grew MercuryMD from inception to $11M in revenue resulting in a successful acquisition by Thomson Healthcare (Truven).

Phillip Johnston Biography

Venture Partner

Phillip Johnston Biography

Phillip Johnston (PJ) is an accomplished HealthTech and PharmaTech executive with extensive experience building and scaling enterprise SaaS solutions for the life sciences industry. He served as Vice President of Product at Certara, where he led the development of Certara Cloud, a centralized platform of shared services supporting more than 15 scientific applications. He has held senior product leadership roles across Certara and its Pinnacle 21 division, driving regulatory compliance, advanced analytics, and platform integration that accelerated clinical trial processes and drug development timelines. As a proven leader in product strategy, he has managed multi-million-dollar R&D investments, overseen acquisitions and integrations, and built high-performance teams spanning product management, design, operations, and customer experience. Earlier in his career, he contributed to pre-clinical drug research at SNBL Japan, where he collaborated with regulators and global sponsors on study designs and supported the site’s first FDA-compliant CDISC SEND data submissions. Mr. Johnston earned a Bachelor of Arts in Humanities and Molecular Biology from Bob Jones University and pursued graduate studies in German Language and Literature at Middlebury College.

Max Kanevsky Biography

Venture Partner

Max Kanevsky Biography

Max Kanevsky is an accomplished healthcare technology executive and innovator with a proven track record of building transformative solutions in clinical data and regulatory compliance. Mr. Kanevsky was previously Chief Technology Officer at Certara (NASDAQ: CERT), where he led global technology strategy and product development across the company’s software portfolio serving pharmaceutical and biotech clients worldwide. Prior to Certara, Mr. Kanevsky was founder and CEO of Pinnacle 21 a leading platform for preparing and validating clinical trial data for FDA and global regulatory submissions. Under his leadership, Pinnacle 21 became the industry standard adopted by top pharmaceutical companies and health authorities alike, before being acquired by Certara. With a unique background that bridges life sciences and software engineering, Mr. Kanevsky brings deep technical expertise and entrepreneurial vision to advancing innovation in healthcare. He holds a B.S. in Biochemistry from the University of the Sciences in Philadelphia and an M.S. in Software Engineering from Drexel University.